Published in PLoS One on February 15, 2017
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03
Cancer statistics in China, 2015. CA Cancer J Clin (2016) 12.92
[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe (1987) 7.27
MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res (2004) 6.98
Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA (2007) 5.35
Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol (2007) 4.40
MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol (2010) 1.98
Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit. Thorax (2013) 1.91
An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. J Mol Diagn (2008) 1.82
MicroRNAs and metastasis: little RNAs go a long way. Cancer Res (2010) 1.73
Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood (2009) 1.70
Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg (2010) 1.63
miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol (2010) 1.56
MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2. PLoS One (2015) 1.48
MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Oncogene (2013) 1.37
Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization. J Transl Med (2011) 1.27
The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. PLoS One (2012) 1.26
microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression. Oncotarget (2014) 1.22
Ultra-deep sequencing reveals the microRNA expression pattern of the human stomach. PLoS One (2010) 1.19
MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells. Mol Cell Biochem (2013) 1.15
microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition. Tumour Biol (2013) 1.12
Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue. J Pathol (2012) 1.12
Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer. Int J Cancer (2011) 1.11
Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening. Tumour Biol (2014) 1.08
MiRNA-mediated control of HLA-G expression and function. PLoS One (2012) 1.08
Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma. Mol Carcinog (2013) 1.03
MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis. Cancer Sci (2014) 1.00
Loss of microRNA-200a expression correlates with tumor progression in breast cancer. Transl Res (2013) 0.96
miR-148a is Associated with Obesity and Modulates Adipocyte Differentiation of Mesenchymal Stem Cells through Wnt Signaling. Sci Rep (2015) 0.92
Expression of miR-148/152 family as potential biomarkers in non-small-cell lung cancer. Med Sci Monit (2015) 0.92
MiR-106a is an independent prognostic marker in patients with glioblastoma. Neuro Oncol (2013) 0.92
Surveillance of pancreatic cancer patients after surgical resection. Ann Surg Oncol (2011) 0.87
Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer. Oncol Rep (2013) 0.87
miRNA analysis of prostate cancer by quantitative real time PCR: comparison between formalin-fixed paraffin embedded and fresh-frozen tissue. Urol Oncol (2009) 0.86
Similarly up-regulated microRNA-106a in matched formalin-fixed paraffin-embedded and fresh frozen samples and the dynamic changes during gastric carcinogenesis and development. Pathol Res Pract (2014) 0.84
Evaluation of miR-29c, miR-124, miR-135a and miR-148a in predicting lymph node metastasis and tumor stage of gastric cancer. Int J Clin Exp Med (2015) 0.82
MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1. Oncol Rep (2015) 0.81
The Role of Mir-148a in Cancer. J Cancer (2016) 0.80
MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway. Am J Med Sci (2016) 0.80
MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer. Oncotarget (2016) 0.80
Down-expression of circulating micro ribonucleic acid (miRNA)-148/152 family in plasma samples of non-small cell lung cancer patients. J Cancer Res Ther (2016) 0.79
Role of epigenetics in lung cancer heterogeneity and clinical implication. Semin Cell Dev Biol (2016) 0.79
Biology of lung cancer: genetic mutation, epithelial-mesenchymal transition, and cancer stem cells. Gen Thorac Cardiovasc Surg (2016) 0.78
MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer. PLoS One (2016) 0.78
Expression and Tissue Distribution of MicroRNA-21 in Malignant and Benign Breast Tissues>. Anticancer Res (2015) 0.78
Early mortality in lung cancer: French prospective multicentre observational study. BMC Pulm Med (2016) 0.77
Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types (Br J Surg 2012; 99: 1149-1154). Br J Surg (2012) 0.77
Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis. Transl Lung Cancer Res (2016) 0.77
MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small-Cell Lung Cancer. Cell Physiol Biochem (2015) 0.77